Usana Health Sciences Inc
USNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$261.07M
Close$
$60.13
321.7% upside
Current Fair Value
321.7% upsideUndervalued by 321.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $261.07 Million |
|---|---|
| Enterprise Value | $92.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.68 |
| Outstanding Shares | 18,486,000 |
Return
| Return on Equity | -4.21% |
|---|---|
| Return on Assets | -3.15% |
| Return on Invested Capital | 2.35% |
Valuation & Multiples
| P/E Ratio | -11.71 |
|---|---|
| PEG | 3.64 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 0.48 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | 6.58 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.43
Average shareholder expectationRevenue Estimate
$235.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$219.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.3047▲ 130.47% |
|---|---|
| Total Calls | 12,800▲ Infinity% |
| Total Puts | 16,700▲ 65.35% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 63.07%▲ 7.21% |
|---|---|
| Total Invested | $248.82M▲ 38.55% |
| Investors Holding | 1400% |
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest